Repeat Catheter Ablation vs. Stereotactic Arrhythmia Radioablation for Recurrent Ventricular Tachycardia in Structural Heart Disease: The STAR-VT-2020 Randomized Trial
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S84-S85
DOI: 10.1016/j.ijrobp.2026.06.098 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von J. Cvek und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Cvek, J., Jiravsky, O., & Knybel, L. (2026). Repeat Catheter Ablation vs. Stereotactic Arrhythmia Radioablation for Recurrent Ventricular Tachycardia in Structural Heart Disease: The STAR-VT-2020 Randomized Trial. International Journal of Radiation Oncology*Biology*Physics, 126(1), S84-S85. https://doi.org/10.1016/j.ijrobp.2026.06.098
Vancouver
Cvek J, Jiravsky O, Knybel L. Repeat Catheter Ablation vs. Stereotactic Arrhythmia Radioablation for Recurrent Ventricular Tachycardia in Structural Heart Disease: The STAR-VT-2020 Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S84-S85. doi:10.1016/j.ijrobp.2026.06.098
BibTeX
@article{Cvek2026,
author = {Cvek, J. and Jiravsky, O. and Knybel, L.},
title = {Repeat Catheter Ablation vs. Stereotactic Arrhythmia Radioablation for Recurrent Ventricular Tachycardia in Structural Heart Disease: The STAR-VT-2020 Randomized Trial},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {S84--S85},
doi = {10.1016/j.ijrobp.2026.06.098}
}
EUVIMED